Abstract
This chapter presents characterization of the db/db mouse model of type 2 diabetes. The protocol describes generation of the mice along with measurements of physical characteristics such as body weight and body composition, and behaviours including food and water consumption. Such a procedure can also be used for omics-based analyses of brain tissues to investigate the potential use of db/db mouse model in neuropsychiatric research. In addition, we present measurement of blood glucose and plasma insulin levels which tend to be elevated in this model and can modulated post treatment with anti-diabetic agents. All of these characteristics can be used for studying the pathophysiology and for monitoring response to potential therapeutics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Scheen AJ (2017) Pharmacological management of type 2 diabetes: what's new in 2017? Expert Rev Clin Pharmacol 10(12):1383–1394
Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153:1127–1128
Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ et al (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84(3):491–495
Chan TM, Young KM, Hutson NJ, Brumley FT, Exton JH (1975) Hepatic metabolism of genetically diabetic (db/db) mice. I. Carbohydrate metabolism. Am J Phys 229(6):1702–1712
Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L (2000) The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49:22–31
Sharma K, McCue P, Dunn SR (2003) Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284(6):F1138–F1144
Wua J, Wang HM, Li J, Men XL (2013) The research applications of db/db mouse. Sheng Li KeXue Jin Zhan 44(1):12–18
Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA et al (2008) Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 86(15):3265–3274
Sharma AN, Elased KM, Garrett TL, Lucot JB (2010) Neurobehavioral deficits in db/db diabetic mice. Physiol Behav 101(3):381–388
Dinel AL, André C, Aubert A, Ferreira G, Layé S, Castanon N (2011) Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One 6(9):e24325. https://doi.org/10.1371/journal.pone.0024325
Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T (2002) Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113:607–615
Ernst A, Sharma AN, Elased KM, Guest PC, Rahmoune H, Bahn S (2013) Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders. Transl Psychiatry 3:e263. https://doi.org/10.1038/tp.2013.42
Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M et al (2011) Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology 36(7):1092–1096
Meyer JM, Davis VG, Goff DC, McEvoy JP, Nasrallah HA, Davis SM et al (2008) Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE schizophrenia trial: prospective data from phase 1. Schizophr Res 101:273–286
Sharma AN, Elased KM, Lucot JB (2012) Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice. J Psychopharmacol 26(5):724–732
Sharma AN, Ligade SS, Sharma JN, Shukla P, Elased KM, Lucot JB (2015) GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats. Metab Brain Dis 30(2):519–522
Taicher GZ, Tinsley FC, Reiderman A, Heiman ML (2003) Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 377:990–1002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Guest, P.C., Rahmoune, H. (2019). Characterization of the db/db Mouse Model of Type 2 Diabetes. In: Guest, P. (eds) Pre-Clinical Models. Methods in Molecular Biology, vol 1916. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8994-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8994-2_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8993-5
Online ISBN: 978-1-4939-8994-2
eBook Packages: Springer Protocols